HCSG

HCSG Cost of Revenue

$1.54BTTM · USD

Period ending:

HCSG FY Cost of RevenueUSD
HCSG FY Cost of Revenue1985-12-31: $16.80M1986-12-31: $24.30M1987-12-31: $24.20M1988-12-31: $30.50M1989-12-31: $43.60M1990-12-31: $51.20M1991-12-31: $73.50M1992-12-31: $83.00M1993-12-31: $94.20M1994-12-31: $112.30M1995-12-31: $124.70M1996-12-31: $137.00M1997-12-31: $152.30M1998-12-31: $172.30M1999-12-31: $203.60M2000-12-31: $226.90M2001-12-31: $252.03M2002-12-31: $289.86M2003-12-31: $334.61M2004-12-31: $388.72M2005-12-31: $406.11M2006-12-31: $438.62M2007-12-31: $493.36M2008-12-31: $521.27M2009-12-31: $597.72M2010-12-31: $665.15M2011-12-31: $766.96M2012-12-31: $930.81M2013-12-31: $995.10M2014-12-31: $1.16B2015-12-31: $1.24B2016-12-31: $1.34B2017-12-31: $1.61B2018-12-31: $1.77B2019-12-31: $1.61B2020-12-31: $1.49B2021-12-31: $1.41B2022-12-31: $1.50B2023-12-31: $1.46B2024-12-31: $1.49B2025-12-31: $1.60B$1.77B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HCSG cost of revenue history

Direct costs attributable to producing goods sold. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Healthcare Services Group Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
1,597,768,000
1,487,592,000
1,456,643,000
1,496,865,000
1,411,393,000
1,492,317,000
1,612,877,000
1,771,981,000
1,612,510,000
1,339,492,000
1,236,108,000
1,155,293,000
995,104,000
930,814,000
766,958,000
665,149,000
597,715,000
521,269,000
493,364,000
438,617,000
406,114,000
388,719,000
334,609,420
289,858,898
252,029,939
226,899,572
203,600,000
172,300,000
152,300,000
137,000,000
124,700,000
112,300,000
94,200,000
83,000,000
73,500,000
51,200,000
43,600,000
30,500,000
24,200,000
24,300,000
16,800,000

Compare cost of revenue

All HCSG financial metrics · HCSG stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.